Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2974694 | 0.83 | — | — | |
| SCHEMBL2973923 | 0.78 | — | — | |
| SCHEMBL2966564 | 0.74 | PLA2G1B (0.30) | — | |
| SCHEMBL2802966 | 0.74 | — | — | |
| SCHEMBL4275605 | 0.72 | — | — | |
| SCHEMBL17006249 | 0.72 | TSHR (0.39) | — | |
| SCHEMBL4113357 | 0.72 | ALDH1A1 (0.40) | — | |
| SCHEMBL4275335 | 0.67 | — | — | |
| SCHEMBL4122364 | 0.67 | LMNA (0.41) | — | |
| SCHEMBL65000 | 0.67 | CYP1A2 (0.53) | CA12CA1CA2CA9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102464599-A | Amido methyl xanthogenic acid cyanoethyl ester compound, preparation method and collecting agent thereof | NORTHWEAT RES INST OF MINING & METALLURG INST | 2012-05-23 | — | — | CN | claimed |
| US-20060100213-A1 | Triazoles and methods of use | AMGEN INC. (US) | 2006-05-11 | — | — | US | claimed |
| CN-1511840-A | Puerarin compound containing water soluble group and its preparation and use | 中国人民解放军军事医学科学院放射医 | 2004-07-14 | — | — | CN | claimed |
| US-5378690-A | Treatment of angiotensin induced hypertension | SANKYO COMPANY, LIMITED (JP) | 1995-01-03 | — | — | US | claimed |
| EP-0274259-B1 | New renin-inhibitory oligopeptides, their preparaton and their use | SANKYO CO (JP) | 1994-02-16 | — | — | EP | claimed |
| EP-0274259-A2 | New renin-inhibitory oligopeptides, their preparaton and their use | Sankyo Company Limited (JP) | 1988-07-13 | — | — | EP | claimed |
| US-11735737-B2 | Binder for electricity storage devices improving dispersibility of conductive assistant | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| EP-4023686-A1 | BINDER FOR ELECTRICITY STORAGE DEVICES IMPROVING DISPERSIBILITY OF CONDUCTIVE ASSISTANT | FUJIFILM Wako Pure Chemical Corporation (JP) | 2022-07-06 | — | — | EP | disclosed |
| US-20220190343-A1 | BINDER FOR ELECTRICITY STORAGE DEVICES IMPROVING DISPERSIBILITY OF CONDUCTIVE ASSISTANT | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| US-20220181633-A1 | BINDER FOR ELECTRICITY STORAGE DEVICES | FUJIFILM CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| CN-113304887-B | Amino xanthate sulfide ore collecting agent and preparation method and application thereof | 北京矿冶研究总院 | 2022-05-31 | — | — | CN | disclosed |
| CN-114270572-A | Binder for electricity storage device | 富士胶片株式会社 | 2022-04-01 | — | — | CN | disclosed |
| CN-113711393-A | Binder for electricity storage device for improving dispersibility of conductive auxiliary agent | 富士胶片和光纯药株式会社 | 2021-11-26 | — | — | CN | disclosed |
| CN-1127506-A | Method of alkylating triazine derivative | NISSAN CHEMICAL IND LTD (JP) | 1996-07-24 | — | — | CN | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-5378690-A | Treatment of angiotensin induced hypertension | SANKYO COMPANY, LIMITED (JP) | 1995-01-03 | — | — | US | disclosed |
| EP-0274259-B1 | New renin-inhibitory oligopeptides, their preparaton and their use | SANKYO CO (JP) | 1994-02-16 | — | — | EP | disclosed |
| US-5270322-A | Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them | DR. KARL THOMAE GMBH (DE) | 1993-12-14 | — | — | US | disclosed |
| EP-0555825-A1 | Imidazo(1,2-a)pyridines as angiotensin-II-antagonists | Dr. Karl Thomae GmbH (DE) | 1993-08-18 | — | — | EP | disclosed |
| EP-0274259-A2 | New renin-inhibitory oligopeptides, their preparaton and their use | Sankyo Company Limited (JP) | 1988-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100213-A1 | Triazoles and methods of use | CYP3A5, CYP3A43, CYP2E1 | CA12 4075/4885CA1 3405/4885CA2 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.